10:00am – 10:10am

Introductions and Overview

Session 1: Taking Stock (profiles in NA): trends, progress towards targets and big scale initiatives

10:10am – 10:25am

Canada – Canada’s STBBI Action Plan 2024-2030 –

10:25am – 10:40am

Mexico – Expansion of HCV management in primary care 

10:40am – 10:55am

United States — US HCV elimination plan

11:00am – 11:15am

PANEL DISCUSSION: Includes patient representation (WHA,NVHR)

Session 2: Diagnostics with the goal of increasing treatment

11:20am – 11:35am

HCV POCT and barriers to test & treat approach

11:35am – 11:50am

HBV testing – what needs to ∆ in policies & practice (qHBsAg, HBV POCT)

11:50am – 12:05pm

HDV: reflex testing, status of anti-HDV & RNA testing in NA

12:05pm – 12:20pm

PANEL DISCUSSION

Session 34: Vaccination – an important cornerstone in Prevention

12:25pm – 12:40pm

Suggest Catch-up HepB Vaccination Strategies for all or at risk adults

12:40pm – 12:55pm

HCV Vaccine trials in NA status report

LUNCH 1pm – 2pm

Session 3:  Prevention Beyond Vaccination

2:05pm – 2:20pm

Next Steps in Elimination of MTCT of HBV and HCV in North America

2:20pm – 2:35pm

Liver cancer in VH in North America – surveillance challenges and solutions

2:35pm – 3:05pm

PANEL DISCUSSION: Includes session 3 speakers also

Session 5: Health equity: Delivering VH care in persons using drugs

3:10pm – 3:25pm

Prevention of HCV among PWID in Mexico 

3:25pm – 3:40pm

PWIDs – novel programs in U.S.

3.40pm – 3:55pm

Supervised injection sites and SSPs in Canada

3:55pm – 4:15pm

PANEL DISCUSSION: Includes patient representation (WHA)

4:15pm – 4:30pm

Wrap-up and Next Steps: Blueprint/Roadmap strategy